Toxicity threshold of quinine hydrochloride following low-level repeated dosing in healthy volunteers
- PMID: 8477913
- DOI: 10.1016/0278-6915(93)90073-8
Toxicity threshold of quinine hydrochloride following low-level repeated dosing in healthy volunteers
Abstract
Following a double-blind, four-way crossover design, 32 healthy volunteers (20 males and 12 females) each consumed lactose placebo, or 80, 120 or 160 mg quinine HCl daily for 21 days. Before dosing and at regular intervals during dosing, blood and urine samples were collected and analysed for quinine HCl. Electrocardiography, heart rate, blood pressure, audiometry, peripheral field, funduscopy, colour vision, visual acuity, electronystagmography (ENG) and test for optokinetic nystagmus were all evaluated before dosing and at selected times during dosing. The results showed that daily consumption of up to 80 mg quinine HCl did not significantly alter physiological, ophthalmic or audiometric responses. ENG determination showed that 12.5% of volunteers given lactose placebo or 80 mg quinine HCl exhibited at least one transitory period of ocular motor oscillations. This phenomenon was observed in 18.8% (P < 0.05) of volunteers with a daily intake of 120 mg quinine HCl or more. However, there was not a significant dose-related correlation between nystagmus and daily intake of quinine HCl. Five volunteers consuming lactose placebo displayed an aberrant ocular flutter that decreased significantly (P < 0.05) as the daily intake of quinine HCl increased. One volunteer showed a change in perception of red/green colour vision after taking 160 mg quinine HCl for 21 days. This study demonstrated that the no-untoward-effect level of quinine HCl is at least 80 mg/day.
Similar articles
-
Ototoxic reactions of quinine in healthy persons and patients with Plasmodium falciparum infection.Auris Nasus Larynx. 1997 Apr;24(2):131-6. doi: 10.1016/S0385-8146(96)00031-4. Auris Nasus Larynx. 1997. PMID: 9134134
-
Electronystagmographic findings in long-term low-dose quinine ingestion. A preliminary report.Arch Otolaryngol. 1984 Dec;110(12):788-91. doi: 10.1001/archotol.1984.00800380018006. Arch Otolaryngol. 1984. PMID: 6334512
-
Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.Br J Clin Pharmacol. 2004 Nov;58 Suppl 1(Suppl 1):41-9. doi: 10.1111/j.1365-2125.2004.01799.x. Br J Clin Pharmacol. 2004. PMID: 15496222 Free PMC article. Clinical Trial.
-
Cardiovascular safety of fexofenadine HCl.Am J Cardiol. 1999 May 15;83(10):1451-4. doi: 10.1016/s0002-9149(99)00124-1. Am J Cardiol. 1999. PMID: 10335761 Review.
-
Quinine toxicity when given with doxycycline and mefloquine.Southeast Asian J Trop Med Public Health. 1994 Jun;25(2):397-400. Southeast Asian J Trop Med Public Health. 1994. PMID: 7855666 Review.
Cited by
-
[Tonic water and quinine-a bicentennial booming cocktail].Rev Fr Allergol (2009). 2021 Oct;61(6):425-431. doi: 10.1016/j.reval.2021.04.002. Epub 2021 May 12. Rev Fr Allergol (2009). 2021. PMID: 33995692 Free PMC article. Review. French.
-
New Insights into Enhancing Maximal Exercise Performance Through the Use of a Bitter Tastant.Sports Med. 2016 Oct;46(10):1385-90. doi: 10.1007/s40279-016-0522-0. Sports Med. 2016. PMID: 27000831 Review.
-
The Gustatory Signaling Pathway and Bitter Taste Receptors Affect the Development of Obesity and Adipocyte Metabolism in Mice.PLoS One. 2015 Dec 21;10(12):e0145538. doi: 10.1371/journal.pone.0145538. eCollection 2015. PLoS One. 2015. PMID: 26692363 Free PMC article.
-
Quinine as a potential tracer for medication adherence: A pharmacokinetic and pharmacodynamic assessment of quinine alone and in combination with oxycodone in humans.J Clin Pharmacol. 2015 Dec;55(12):1332-43. doi: 10.1002/jcph.557. Epub 2015 Jul 29. J Clin Pharmacol. 2015. PMID: 26032168 Free PMC article. Clinical Trial.
-
Adverse effects of chemotherapeutic agents used in tropical medicine.Drug Saf. 1995 Jul;13(1):31-45. doi: 10.2165/00002018-199513010-00005. Drug Saf. 1995. PMID: 8527018 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources